These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1008 related articles for article (PubMed ID: 31707324)

  • 1. Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS.
    Pagidipati NJ; Zheng Y; Green JB; McGuire DK; Mentz RJ; Shah S; Aschner P; Delibasi T; Rodbard HW; Westerhout CM; Holman RR; Peterson ED;
    Am Heart J; 2020 Jan; 219():47-57. PubMed ID: 31707324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease.
    Shavadia JS; Zheng Y; Green JB; Armstrong PW; Westerhout CM; McGuire DK; Cornel JH; Holman RR; Peterson ED
    Am Heart J; 2019 Dec; 218():92-99. PubMed ID: 31715435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS.
    Nauck MA; McGuire DK; Pieper KS; Lokhnygina Y; Strandberg TE; Riefflin A; Delibasi T; Peterson ED; White HD; Scott R; Holman RR
    Cardiovasc Diabetol; 2019 Sep; 18(1):116. PubMed ID: 31481069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients.
    Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Nunez L; Gudbjörnsdóttir S; Eliasson B
    Diabetologia; 2009 Jan; 52(1):65-73. PubMed ID: 18985314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype.
    Standl E; Stevens SR; Armstrong PW; Buse JB; Chan JCN; Green JB; Lachin JM; Scheen A; Travert F; Van de Werf F; Peterson ED; Holman RR;
    Diabetes Care; 2018 Mar; 41(3):596-603. PubMed ID: 29311155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial.
    Sharma A; Green JB; Dunning A; Lokhnygina Y; Al-Khatib SM; Lopes RD; Buse JB; Lachin JM; Van de Werf F; Armstrong PW; Kaufman KD; Standl E; Chan JCN; Distiller LA; Scott R; Peterson ED; Holman RR;
    Diabetes Care; 2017 Dec; 40(12):1763-1770. PubMed ID: 28986504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS.
    De Ferrari GM; Stevens SR; Ambrosio G; Leonardi S; Armstrong PW; Green JB; Wamil M; Holman RR; Peterson ED;
    Am Heart J; 2020 Feb; 220():82-88. PubMed ID: 31790905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of Body Mass Index to Outcomes in Acute Coronary Syndrome.
    Ratwatte S; Hyun K; D'Souza M; Barraclough J; Chew DP; Shetty P; Patel S; Amos D; Brieger D;
    Am J Cardiol; 2021 Jan; 138():11-19. PubMed ID: 33058799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
    Bethel MA; Green JB; Milton J; Tajar A; Engel SS; Califf RM; Holman RR;
    Diabetes Obes Metab; 2015 Apr; 17(4):395-402. PubMed ID: 25600421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent relationships between body mass index and mortality: Singapore longitudinal ageing study.
    Ng TP; Jin A; Chow KY; Feng L; Nyunt MSZ; Yap KB
    PLoS One; 2017; 12(7):e0180818. PubMed ID: 28738068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.
    Alfredsson J; Green JB; Stevens SR; Reed SD; Armstrong PW; Angelyn Bethel M; Engel SS; McGuire DK; Van de Werf F; Hramiak I; White HD; Peterson ED; Holman RR;
    Diabetes Obes Metab; 2018 Oct; 20(10):2379-2388. PubMed ID: 29923323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events.
    Ferdinand KC; Botros FT; Atisso CM; Sager PT
    Cardiovasc Diabetol; 2016 Feb; 15():38. PubMed ID: 26912057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of body mass index and long-term outcomes in older patients with non-ST-segment-elevation myocardial infarction: results from the CRUSADE Registry.
    O'Brien EC; Fosbol EL; Peng SA; Alexander KP; Roe MT; Peterson ED
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):102-9. PubMed ID: 24326936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of obesity on metabolic and cardiovascular outcomes following insulin initiation in patients with type 2 diabetes.
    Anyanwagu U; Mamza J; Donnelly R; Idris I
    Obes Res Clin Pract; 2018; 12(1):72-84. PubMed ID: 28939465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study.
    Costanzo P; Cleland JG; Pellicori P; Clark AL; Hepburn D; Kilpatrick ES; Perrone-Filardi P; Zhang J; Atkin SL
    Ann Intern Med; 2015 May; 162(9):610-8. PubMed ID: 25938991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index and cardiovascular outcomes in patients with acute coronary syndrome by diabetes status: the obesity paradox in a Korean national cohort study.
    Park SJ; Ha KH; Kim DJ
    Cardiovasc Diabetol; 2020 Nov; 19(1):191. PubMed ID: 33172464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index and mortality in patients with type 2 diabetes mellitus: A prospective cohort study of 11,449 participants.
    Liu H; Wu S; Li Y; Sun L; Huang Z; Lin L; Liu Y; Ji C; Zhao H; Li C; Song L; Cong H
    J Diabetes Complications; 2017 Feb; 31(2):328-333. PubMed ID: 27887863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the association of hypertension with cardiovascular events stronger among the lean and normal weight than among the overweight and obese? The multi-ethnic study of atherosclerosis.
    Colangelo LA; Vu TH; Szklo M; Burke GL; Sibley C; Liu K
    Hypertension; 2015 Aug; 66(2):286-93. PubMed ID: 26077561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study.
    Rådholm K; Chalmers J; Ohkuma T; Peters S; Poulter N; Hamet P; Harrap S; Woodward M
    Diabetes Obes Metab; 2018 Aug; 20(8):1903-1910. PubMed ID: 29603537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity.
    Khan SS; Ning H; Wilkins JT; Allen N; Carnethon M; Berry JD; Sweis RN; Lloyd-Jones DM
    JAMA Cardiol; 2018 Apr; 3(4):280-287. PubMed ID: 29490333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.